Clinical trial

Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer

NCT01338012

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-12-01

PhasePHASE2

Study timeline

Study start (unknown)2011-12-01Date precision: month

Registry last updated2017-06-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

sipuleucel-TBIOLOGICAL

Sponsors & collaborators

Dendreonlead sponsor

Mapped research locations

SeattleWashington, United States2 PortlandOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01338012 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.